Recombinant CTBP2 protein (His tag)

Recombinant CTBP2 protein (His tag)

Cat.#: 547098

Size:

Special Price 294.7 USD

Availability: 3-4 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Recombinant CTBP2 protein (His tag)
  • Documents
  • Description

    Recombinant Human C-terminal-binding protein 2 (CtBP2) fragment (residues 31-362) is a high-quality, stable protein designed for structural and biochemical studies. This 332-amino acid fragment, derived from the CTBP2 gene, represents a soluble and functional unit ideal for investigating CtBP2's role as a transcriptional corepressor and its involvement in cellular processes such as brown adipose tissue differentiation.

    C-terminal-binding protein 2 (CtBP2), encoded by the CTBP2 gene in humans, functions as a corepressor that targets diverse transcription regulators. It plays a critical role in biological processes including brown adipose tissue differentiation. Additionally, specific isoforms, such as Isoform 2, are implicated in acting as scaffolds for specialized synapses. The protein is primarily localized to the nucleus, with synaptic presence highlighting its involvement in neural functions. This recombinant fragment (residues 31-362) was selected computationally to ensure stability and solubility, enabling reliable use in experimental applications without the complexities of the full-length protein.

  • Protein name
    C-terminal-binding protein 2
  • Uniprot ID
    P56545
  • Gene Name
    CTBP2
  • Source/Expression Host
    E. coli
  • Expression Plasmid/cDNA
    DNA encoding 31-362 aa (P56545) were fused with 6His tag.
  • Protein Species
    Human
  • Molecular weight
    Predictes a molecular mass of 38.47 kDa. In SDS-PAGE under reducing conditions, it migrates as an approximately 39 kDa band.
  • Purity
    >85%, by SDS-PAGE with Coomassie Brilliant Blue staining.
  • Activity
    Not tested.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"